FSRH Guideline Intrauterine Contraception
... imaging NICE National Institute for Health and Care Excellence NSAID nonsteroidal anti-inflammatory drug OR odds ratio PI Pearl Index PID pelvic inflammatory disease POP progestogen-only pill PPIUC ...
FSRH Clinical Guideline: Progestogen-only Pills (August 2022, Amended November 2022)
... 11 9.5 Drug interactions ...
FSRH CEU Guidance: Drug Interactions with Hormonal Contraception (May 2022)
... cookies are set via our cookie settings page. I'm OK with that Let me choose FSRH CEU Guidance: Drug Interactions with Hormonal Contraception (May 2022) 337d60caa243dbce0c4c9dfa040db2e4 Published on: 9 ...
FSRH CEU Clinical Guidance Workplan for 2022/23
... 2022 2023 Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Progestogen-only Pill (update) HIV Drug Interactions with Hormonal Contraception (new) Switching or Starting Methods of Contraception ...
FSRH CEU new product review: Drovelis® estetrol/drospirenone combined oral contraceptive (October 2022)
... European/Russian phase III study[4], 9.1% discontinued because of apparent side effects of E4/DRSP. Drug interaction Key information: As with other CHC, the contraceptive effectiveness of E4/DRSP could be ...
FSRH Service Standards for Clinical Risk Management in SRH - October 2022
... provided with supply of medicine 5.4 Inadequate medical history leading to inability to prevent drug interaction and anaphylaxis 5.5 Lack of security to prevent theft of drugs and prescription ...
FSRH Progestogen-only Pills National Benchmarking Audit
... women prescribed progestogen-only pills (POP) what percentage of women... 1. ...had a comprehensive drug history taken? 2. ...using an enzyme-inducing drug were offered effective contraception that is not ...
FSRH CEU response to public consultation comments POP Guideline
... and blood pressure, for example”. This is early in guidance and risks conversion to a guidance and drug promotion point. Suggestion indicate that it is below a level D and not yet good practice Amended in ...
Membership Exam Part I Handbook (MFSRH)
... only D. It is considered safe to use in pregnant women E. Methemoglobinemia never occurs with this drug MFSRH Part I Handbook Last Reviewed: April 2022 Page 8 of 34 CiP 4 Data 4. In order to allocate ...